• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
CUV 0.45% $15.69

CLINUVEL PHARMACEUTICALS LIMITED - Announcements

Clinuvel Pharmaceuticals Limited is an Australia-based global specialty pharmaceutical... Clinuvel Pharmaceuticals Limited is an Australia-based global specialty pharmaceutical company. The Company is focused on developing and commercializing treatments for patients with genetic, metabolic, systemic, and life-threatening, acute disorders, as well as healthcare solutions for specialized populations. Its lead therapy, SCENESSE (afamelanotide 16mg), is approved for commercial distribution in Europe, the USA, Israel, and Australia as the first systemic photoprotective drug for the prevention of phototoxicity (anaphylactoid reactions and burns) in adult patients with erythropoietic protoporphyria (EPP). The Company’s pharmaceuticals product development includes PRENUMBRA and NEURACTHEL. Its PhotoCosmetics product development includes CYACELLE and DNA Repair Assist and Melanogenesis. PRENUMBRA is a formulation of afamelanotide designed to provide a flexible dose in identified patient groups. NEURACTHEL is a novel formulation of the melanocortin adrenocorticotropic hormone (ACTH).More

Announcements


CUV CLINUVEL Newsletter VI - December 202223/12/22 download Created with Sketch. 246.06KB
CUV Notification of cessation of securities - CUV21/12/22 download Created with Sketch. 21.48KB
CUV Presentation - Jefferies London Healthcare Conference17/11/22 download Created with Sketch. 3.31MB
CUV CLINUVEL Newsletter V - November 202209/11/22 download Created with Sketch. 546.94KB
CUV Change of Director's Interest Notice07/11/22 download Created with Sketch. 216.26KB
CUV Quarterly Activities/Appendix 4C Cash Flow Report Re-issuedPRICE SENSITIVE31/10/22 download Created with Sketch. 348.75KB
CUV Quarterly Activities/Appendix 4C Cash Flow ReportPRICE SENSITIVE31/10/22 download Created with Sketch. 347.86KB
CUV Results of Meeting26/10/22 download Created with Sketch. 144.34KB
CUV Chair Address26/10/22 download Created with Sketch. 321.32KB
CUV Melbourne Investor Briefing Presentation21/10/22 download Created with Sketch. 2.68MB
CUV First vitiligo patient enrolled in monotherapy study20/10/22 download Created with Sketch. 151.05KB
CUV Investor Presentation - Sydney14/10/22 download Created with Sketch. 3.31MB
CUV Notice of Annual General Meeting/Proxy Form23/09/22 download Created with Sketch. 3.86MB
CUV Strategic Update V19/09/22 download Created with Sketch. 408.93KB
CUV Presentation - HC Wainright Global Investment Conference13/09/22 download Created with Sketch. 869KB
CUV Annual General Meeting Date08/09/22 download Created with Sketch. 391.42KB
CUV CLINUVEL submits label expansion for adolescent EPP patients05/09/22 download Created with Sketch. 157.73KB
CUV S&P DJI Announces September 2022 Quarterly RebalancePRICE SENSITIVE02/09/22 download Created with Sketch. 134KB
CUV CLINUVEL Investor Webinar Financial Results 202231/08/22 download Created with Sketch. 2.1MB
CUV Appendix 4G and Corporate Governance Statement30/08/22 download Created with Sketch. 2.57MB
CUV Revenue Growth Drives CLINUVEL's Full Year Profit30/08/22 download Created with Sketch. 309.29KB
CUV Dividend/Distribution - CUV30/08/22 download Created with Sketch. 22.38KB
CUV Appendix 4E and Annual Report 2022PRICE SENSITIVE30/08/22 download Created with Sketch. 17.97MB
CUV CLINUVEL Newsletter IV - August 202223/08/22 download Created with Sketch. 441.77KB
CUV Chair's Letter05/08/22 download Created with Sketch. 190.08KB
CUV PRENUMBRA Instant Formulation for Stroke28/07/22 download Created with Sketch. 164.02KB
CUV Quarterly Activities/Appendix 4C Cash Flow ReportPRICE SENSITIVE25/07/22 download Created with Sketch. 249.09KB
CUV Change of Director's Interest Notice23/06/22 download Created with Sketch. 230.56KB
CUV CLINUVEL Newsletter III - June 202223/06/22 download Created with Sketch. 695.71KB
CUV Change of Director's Interest Notice14/06/22 download Created with Sketch. 230.59KB
CUV Ceasing to be a substantial holder14/06/22 download Created with Sketch. 1.1MB
CUV H.C. Wainwright Global Investment Conference Presentation26/05/22 download Created with Sketch. 661.41KB
CUV Change in substantial holding25/05/22 download Created with Sketch. 1.24MB
CUV Becoming a substantial holder20/05/22 download Created with Sketch. 1.58MB
CUV CLINUVEL Strategic Update IV - May 202213/05/22 download Created with Sketch. 127.21KB
CUV Change of Director's Interest Notice x 212/05/22 download Created with Sketch. 273.41KB
CUV CLINUVEL Progresses CUV104 Vitiligo Study10/05/22 download Created with Sketch. 138.18KB
CUV Notification regarding unquoted securities - CUV06/05/22 download Created with Sketch. 25.32KB
CUV Positive Final Results in Stroke Study CUV801PRICE SENSITIVE04/05/22 download Created with Sketch. 327.4KB
CUV CEO Letter29/04/22 download Created with Sketch. 242.37KB
CUV Quarterly Activities/Appendix 4C Cash Flow ReportPRICE SENSITIVE28/04/22 download Created with Sketch. 371.79KB
CUV Notice of ceasing to be a substantial holder27/04/22 download Created with Sketch. 465.97KB
CUV Initial Director's Interest Notice07/04/22 download Created with Sketch. 161.53KB
CUV Chair's Letter06/04/22 download Created with Sketch. 184.17KB
CUV CLINUVEL appoints new Non-Executive Director04/04/22 download Created with Sketch. 107.45KB
CUV CLINUVEL Extends CEO Employment Agreement01/04/22 download Created with Sketch. 2.1MB
CUV CLINUVEL Newsletter II - March 202231/03/22 download Created with Sketch. 2.48MB
CUV First XP-V Patient Treated in Third CUV DNA Repair Study30/03/22 download Created with Sketch. 148.69KB
CUV Change of Director's Interest Notice23/03/22 download Created with Sketch. 314.8KB
CUV ACTH Manufacturing UpdatePRICE SENSITIVE17/03/22 download Created with Sketch. 201.09KB
CUV afamelanotide in Stroke (AIS) - Positive Preliminary ResultsPRICE SENSITIVE15/03/22 download Created with Sketch. 207.06KB
CUV Change of Director's Interest Notice02/03/22 download Created with Sketch. 251.5KB
CUV CEO Letter28/02/22 download Created with Sketch. 324.65KB
CUV CLINUVEL Reports December Half Year Operating ResultsPRICE SENSITIVE23/02/22 download Created with Sketch. 97.26KB
CUV Appendix 4D Half Year ReportPRICE SENSITIVE23/02/22 download Created with Sketch. 974.45KB
CUV Operations Update I Financial Results Webinar16/02/22 download Created with Sketch. 151.05KB
CUV CLINUVEL Expands DNA Repair Program with 2nd Study14/02/22 download Created with Sketch. 125.5KB
CUV Quarterly Activities/Appendix 4C Cash Flow ReportPRICE SENSITIVE31/01/22 download Created with Sketch. 281.53KB
CUV CLINUVEL Newsletter I - January 2227/01/22 download Created with Sketch. 482.43KB
CUV SCENESSE Continued in Germany24/01/22 download Created with Sketch. 110.19KB
CUV Change of Director's Interest Notice19/01/22 download Created with Sketch. 231.08KB
CUV Notification of cessation of securities - CUV19/01/22 download Created with Sketch. 21.49KB
CUV CLINUVEL completes enrolment in CUV801 Stroke Study17/01/22 download Created with Sketch. 142.76KB
CUV Presentation - H.C. Wainwright Bioconnect Conference 202210/01/22 download Created with Sketch. 876.19KB
CUV Progress update to DNA Repair Program23/12/21 download Created with Sketch. 112.53KB
CUV Chair Letter21/12/21 download Created with Sketch. 996.82KB
CUV CLINUVEL Newsletter 6 - December 202120/12/21 download Created with Sketch. 148.49KB
CUV CLINUVEL Study to Evaluate SCENESSE as Vitiligo Monotherapy20/12/21 download Created with Sketch. 106.39KB
CUV CLINUVEL Newsletter 5 - November 202122/11/21 download Created with Sketch. 355.86KB
CUV Presentation Jefferies London Healthcare Conference18/11/21 download Created with Sketch. 777.71KB
CUV Results of Meeting11/11/21 download Created with Sketch. 142.94KB
CUV Managing Director AGM Presentation10/11/21 download Created with Sketch. 3.09MB
CUV Chair Address10/11/21 download Created with Sketch. 110.66KB
CUV CLINUVEL Strategic Update III - November 202108/11/21 download Created with Sketch. 166.34KB
CUV Media release - CLINUVEL Expands Pharmaceutical Portfolio08/11/21 download Created with Sketch. 295.65KB
CUV CLINUVEL adds ACTH to portfolio08/11/21 download Created with Sketch. 382.63KB
CUV Response to ASX Price QueryPRICE SENSITIVE08/11/21 download Created with Sketch. 257.36KB
CUV Quarterly Activities/Appendix 4C Cash Flow ReportPRICE SENSITIVE28/10/21 download Created with Sketch. 203.94KB
CUV CLINUVEL Investor Webinar Released26/10/21 download Created with Sketch. 113.74KB
CUV First Patient Treated in CLINUVEL DNA Repair Study22/10/21 download Created with Sketch. 133.25KB
CUV Investor Webinar18/10/21 download Created with Sketch. 121.42KB
CUV Appendix 4G and Corporate Governance Statement08/10/21 download Created with Sketch. 489.02KB
CUV Notice of Annual General Meeting/Proxy Form08/10/21 download Created with Sketch. 443.89KB
CUV Annual Report to shareholders08/10/21 download Created with Sketch. 6.09MB
CUV Operations Update Webcast II07/10/21 download Created with Sketch. 80.98KB
CUV CLINUVEL Progresses DNA Repair Program05/10/21 download Created with Sketch. 160.99KB
CUV CLINUVEL Key Events and Announcements23/09/21 download Created with Sketch. 214.87KB
CUV CLINUVEL Confirms AGM Date22/09/21 download Created with Sketch. 150.2KB
CUV Notification regarding unquoted securities - CUV16/09/21 download Created with Sketch. 26.63KB
CUV Presentation H.C. Wainwright Global Investment Conference14/09/21 download Created with Sketch. 544.58KB
CUV CLINUVEL Investor Webinar Financial Results27/08/21 download Created with Sketch. 521.9KB
CUV Dividend/Distribution - CUV26/08/21 download Created with Sketch. 22.39KB
CUV CLINUVEL Newsletter 4 - August 202126/08/21 download Created with Sketch. 441.51KB
CUV Corporate Presentation - FY2021 Results26/08/21 download Created with Sketch. 673.08KB
CUV CLINUVEL Delivers Record Revenues and ProfitPRICE SENSITIVE26/08/21 download Created with Sketch. 407.94KB
CUV Appendix 4E and Preliminary Financial ReportPRICE SENSITIVE26/08/21 download Created with Sketch. 1.63MB
CUV Afamelanotide well tolerated by first stroke patients10/08/21 download Created with Sketch. 346.98KB
CUV Quarterly Activities/Appendix 4C Cash Flow ReportPRICE SENSITIVE29/07/21 download Created with Sketch. 351.59KB
CUV Change of Director's Interest Notice05/07/21 download Created with Sketch. 259.65KB
CUV Change of Director's Interest Notice29/06/21 download Created with Sketch. 231.07KB
CUV CLINUVEL Newsletter VI - December 2022
23/12/22 download Created with Sketch. 246.06KB
CUV Notification of cessation of securities - CUV
21/12/22 download Created with Sketch. 21.48KB
CUV Presentation - Jefferies London Healthcare Conference
17/11/22 download Created with Sketch. 3.31MB
CUV CLINUVEL Newsletter V - November 2022
09/11/22 download Created with Sketch. 546.94KB
CUV Change of Director's Interest Notice
07/11/22 download Created with Sketch. 216.26KB
CUV Quarterly Activities/Appendix 4C Cash Flow Report Re-issued
31/10/22PRICE SENSITIVE download Created with Sketch. 348.75KB
CUV Quarterly Activities/Appendix 4C Cash Flow Report
31/10/22PRICE SENSITIVE download Created with Sketch. 347.86KB
CUV Results of Meeting
26/10/22 download Created with Sketch. 144.34KB
CUV Chair Address
26/10/22 download Created with Sketch. 321.32KB
CUV Melbourne Investor Briefing Presentation
21/10/22 download Created with Sketch. 2.68MB
CUV First vitiligo patient enrolled in monotherapy study
20/10/22 download Created with Sketch. 151.05KB
CUV Investor Presentation - Sydney
14/10/22 download Created with Sketch. 3.31MB
CUV Notice of Annual General Meeting/Proxy Form
23/09/22 download Created with Sketch. 3.86MB
CUV Strategic Update V
19/09/22 download Created with Sketch. 408.93KB
CUV Presentation - HC Wainright Global Investment Conference
13/09/22 download Created with Sketch. 869KB
CUV Annual General Meeting Date
08/09/22 download Created with Sketch. 391.42KB
CUV CLINUVEL submits label expansion for adolescent EPP patients
05/09/22 download Created with Sketch. 157.73KB
CUV S&P DJI Announces September 2022 Quarterly Rebalance
02/09/22PRICE SENSITIVE download Created with Sketch. 134KB
CUV CLINUVEL Investor Webinar Financial Results 2022
31/08/22 download Created with Sketch. 2.1MB
CUV Appendix 4G and Corporate Governance Statement
30/08/22 download Created with Sketch. 2.57MB
CUV Revenue Growth Drives CLINUVEL's Full Year Profit
30/08/22 download Created with Sketch. 309.29KB
CUV Dividend/Distribution - CUV
30/08/22 download Created with Sketch. 22.38KB
CUV Appendix 4E and Annual Report 2022
30/08/22PRICE SENSITIVE download Created with Sketch. 17.97MB
CUV CLINUVEL Newsletter IV - August 2022
23/08/22 download Created with Sketch. 441.77KB
CUV Chair's Letter
05/08/22 download Created with Sketch. 190.08KB
CUV PRENUMBRA Instant Formulation for Stroke
28/07/22 download Created with Sketch. 164.02KB
CUV Quarterly Activities/Appendix 4C Cash Flow Report
25/07/22PRICE SENSITIVE download Created with Sketch. 249.09KB
CUV Change of Director's Interest Notice
23/06/22 download Created with Sketch. 230.56KB
CUV CLINUVEL Newsletter III - June 2022
23/06/22 download Created with Sketch. 695.71KB
CUV Change of Director's Interest Notice
14/06/22 download Created with Sketch. 230.59KB
CUV Ceasing to be a substantial holder
14/06/22 download Created with Sketch. 1.1MB
CUV H.C. Wainwright Global Investment Conference Presentation
26/05/22 download Created with Sketch. 661.41KB
CUV Change in substantial holding
25/05/22 download Created with Sketch. 1.24MB
CUV Becoming a substantial holder
20/05/22 download Created with Sketch. 1.58MB
CUV CLINUVEL Strategic Update IV - May 2022
13/05/22 download Created with Sketch. 127.21KB
CUV Change of Director's Interest Notice x 2
12/05/22 download Created with Sketch. 273.41KB
CUV CLINUVEL Progresses CUV104 Vitiligo Study
10/05/22 download Created with Sketch. 138.18KB
CUV Notification regarding unquoted securities - CUV
06/05/22 download Created with Sketch. 25.32KB
CUV Positive Final Results in Stroke Study CUV801
04/05/22PRICE SENSITIVE download Created with Sketch. 327.4KB
CUV CEO Letter
29/04/22 download Created with Sketch. 242.37KB
CUV Quarterly Activities/Appendix 4C Cash Flow Report
28/04/22PRICE SENSITIVE download Created with Sketch. 371.79KB
CUV Notice of ceasing to be a substantial holder
27/04/22 download Created with Sketch. 465.97KB
CUV Initial Director's Interest Notice
07/04/22 download Created with Sketch. 161.53KB
CUV Chair's Letter
06/04/22 download Created with Sketch. 184.17KB
CUV CLINUVEL appoints new Non-Executive Director
04/04/22 download Created with Sketch. 107.45KB
CUV CLINUVEL Extends CEO Employment Agreement
01/04/22 download Created with Sketch. 2.1MB
CUV CLINUVEL Newsletter II - March 2022
31/03/22 download Created with Sketch. 2.48MB
CUV First XP-V Patient Treated in Third CUV DNA Repair Study
30/03/22 download Created with Sketch. 148.69KB
CUV Change of Director's Interest Notice
23/03/22 download Created with Sketch. 314.8KB
CUV ACTH Manufacturing Update
17/03/22PRICE SENSITIVE download Created with Sketch. 201.09KB
CUV afamelanotide in Stroke (AIS) - Positive Preliminary Results
15/03/22PRICE SENSITIVE download Created with Sketch. 207.06KB
CUV Change of Director's Interest Notice
02/03/22 download Created with Sketch. 251.5KB
CUV CEO Letter
28/02/22 download Created with Sketch. 324.65KB
CUV CLINUVEL Reports December Half Year Operating Results
23/02/22PRICE SENSITIVE download Created with Sketch. 97.26KB
CUV Appendix 4D Half Year Report
23/02/22PRICE SENSITIVE download Created with Sketch. 974.45KB
CUV Operations Update I Financial Results Webinar
16/02/22 download Created with Sketch. 151.05KB
CUV CLINUVEL Expands DNA Repair Program with 2nd Study
14/02/22 download Created with Sketch. 125.5KB
CUV Quarterly Activities/Appendix 4C Cash Flow Report
31/01/22PRICE SENSITIVE download Created with Sketch. 281.53KB
CUV CLINUVEL Newsletter I - January 22
27/01/22 download Created with Sketch. 482.43KB
CUV SCENESSE Continued in Germany
24/01/22 download Created with Sketch. 110.19KB
CUV Change of Director's Interest Notice
19/01/22 download Created with Sketch. 231.08KB
CUV Notification of cessation of securities - CUV
19/01/22 download Created with Sketch. 21.49KB
CUV CLINUVEL completes enrolment in CUV801 Stroke Study
17/01/22 download Created with Sketch. 142.76KB
CUV Presentation - H.C. Wainwright Bioconnect Conference 2022
10/01/22 download Created with Sketch. 876.19KB
CUV Progress update to DNA Repair Program
23/12/21 download Created with Sketch. 112.53KB
CUV Chair Letter
21/12/21 download Created with Sketch. 996.82KB
CUV CLINUVEL Newsletter 6 - December 2021
20/12/21 download Created with Sketch. 148.49KB
CUV CLINUVEL Study to Evaluate SCENESSE as Vitiligo Monotherapy
20/12/21 download Created with Sketch. 106.39KB
CUV CLINUVEL Newsletter 5 - November 2021
22/11/21 download Created with Sketch. 355.86KB
CUV Presentation Jefferies London Healthcare Conference
18/11/21 download Created with Sketch. 777.71KB
CUV Results of Meeting
11/11/21 download Created with Sketch. 142.94KB
CUV Managing Director AGM Presentation
10/11/21 download Created with Sketch. 3.09MB
CUV Chair Address
10/11/21 download Created with Sketch. 110.66KB
CUV CLINUVEL Strategic Update III - November 2021
08/11/21 download Created with Sketch. 166.34KB
CUV Media release - CLINUVEL Expands Pharmaceutical Portfolio
08/11/21 download Created with Sketch. 295.65KB
CUV CLINUVEL adds ACTH to portfolio
08/11/21 download Created with Sketch. 382.63KB
CUV Response to ASX Price Query
08/11/21PRICE SENSITIVE download Created with Sketch. 257.36KB
CUV Quarterly Activities/Appendix 4C Cash Flow Report
28/10/21PRICE SENSITIVE download Created with Sketch. 203.94KB
CUV CLINUVEL Investor Webinar Released
26/10/21 download Created with Sketch. 113.74KB
CUV First Patient Treated in CLINUVEL DNA Repair Study
22/10/21 download Created with Sketch. 133.25KB
CUV Investor Webinar
18/10/21 download Created with Sketch. 121.42KB
CUV Appendix 4G and Corporate Governance Statement
08/10/21 download Created with Sketch. 489.02KB
CUV Notice of Annual General Meeting/Proxy Form
08/10/21 download Created with Sketch. 443.89KB
CUV Annual Report to shareholders
08/10/21 download Created with Sketch. 6.09MB
CUV Operations Update Webcast II
07/10/21 download Created with Sketch. 80.98KB
CUV CLINUVEL Progresses DNA Repair Program
05/10/21 download Created with Sketch. 160.99KB
CUV CLINUVEL Key Events and Announcements
23/09/21 download Created with Sketch. 214.87KB
CUV CLINUVEL Confirms AGM Date
22/09/21 download Created with Sketch. 150.2KB
CUV Notification regarding unquoted securities - CUV
16/09/21 download Created with Sketch. 26.63KB
CUV Presentation H.C. Wainwright Global Investment Conference
14/09/21 download Created with Sketch. 544.58KB
CUV CLINUVEL Investor Webinar Financial Results
27/08/21 download Created with Sketch. 521.9KB
CUV Dividend/Distribution - CUV
26/08/21 download Created with Sketch. 22.39KB
CUV CLINUVEL Newsletter 4 - August 2021
26/08/21 download Created with Sketch. 441.51KB
CUV Corporate Presentation - FY2021 Results
26/08/21 download Created with Sketch. 673.08KB
CUV CLINUVEL Delivers Record Revenues and Profit
26/08/21PRICE SENSITIVE download Created with Sketch. 407.94KB
CUV Appendix 4E and Preliminary Financial Report
26/08/21PRICE SENSITIVE download Created with Sketch. 1.63MB
CUV Afamelanotide well tolerated by first stroke patients
10/08/21 download Created with Sketch. 346.98KB
CUV Quarterly Activities/Appendix 4C Cash Flow Report
29/07/21PRICE SENSITIVE download Created with Sketch. 351.59KB
CUV Change of Director's Interest Notice
05/07/21 download Created with Sketch. 259.65KB
CUV Change of Director's Interest Notice
29/06/21 download Created with Sketch. 231.07KB
(20min delay)
Last
$15.69
Change
0.070(0.45%)
Mkt cap ! $786.1M
Open High Low Value Volume
$15.68 $15.98 $15.58 $1.543M 98.04K

Buyers (Bids)

No. Vol. Price($)
1 256 $15.61
 

Sellers (Offers)

Price($) Vol. No.
$15.77 256 1
View Market Depth
Last trade - 16.10pm 28/05/2024 (20 minute delay) ?
Last
$15.70
  Change
0.070 ( 0.36 %)
Open High Low Volume
$15.68 $15.97 $15.60 6072
Last updated 15.59pm 28/05/2024 ?
CUV (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.